Mary Crowley Medical Research Center

Dallas, Texas 76201

0 studies enrolling now · 75 studies all time

What they study most

Adenocarcinoma, Adult Solid Tumor, Advanced Solid Tumors, Anaplastic Astrocytoma, Bladder Neoplasms, Breast Cancer, Breast Cancer Nos Metastatic Recurrent, Cancer, Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Hepatocellular, Carcinoma, Non-Small Cell Lung

Studies at this site

• Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study — Running, not enrolling
• Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) — Running, not enrolling
• A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors — Completed
• Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer. — Stopped early
• SGI-110 in Combination With Carboplatin in Ovarian Cancer — Completed
• SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC) — Completed
• Study of Cabozantinib (XL184) in Adults With Advanced Malignancies — Completed
• Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer — Completed
• A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies — Stopped early
• Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma — Completed
• Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies. — Completed
• Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer — Stopped early
• Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma — Stopped early
• A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy. — Stopped early
• CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL — Withdrawn before enrolling
• Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole — Completed
• A Study to Investigate the Effect of Itraconazole and Rifampin on Pharmacokinetics (PK) of Vemurafenib at Steady State — Completed
• A Study to Investigate the Bioequivalence or Relative Bioavailability of Three New Idasanutlin Tablet Variants Following Oral Administration in Participants With Solid Tumors — Completed
• Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid Tumors — Completed
• A Study of Rovalpituzumab Tesirine to Study Cardiac Ventricular Repolarization in Subjects With Small Cell Lung Cancer — Completed
• Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver — Completed
• Safety Study of Infusion of SGT-53 to Treat Solid Tumors — Completed
• A Study of ARQ 171 in Patients With Advanced Solid Tumors — Stopped early
• Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer — Stopped early
• Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer — Completed
• Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma — Completed
• Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer — Stopped early
• An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma — Completed
• Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy — Completed
• A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical Care — Stopped early
• Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal Adenocarcinoma — Status unconfirmed
• Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior Chemotherapy — Completed
• Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors — Completed
• Clofarabine in Adult Patients With Advanced Solid Tumors — Completed
• Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLC — Completed
• Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS) — Completed
• VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy — Completed
• Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective. — Withdrawn before enrolling
• An Extension Study for Patients Previously Treated With ARQ 501 — Completed
• Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC) — Stopped early
• A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer — Stopped early
• Efficacy and Safety Study of Imprime PGG With Cetuximab in Subjects With Stage IV KRAS-Mutated Colorectal Cancer — Completed
• INNO-206 in Patients With Small Cell Lung Cancer (SCLC) — Withdrawn before enrolling
• A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) — Completed
• TNFerade™ Biologic Plus Radiation for Metastatic Melanoma — Completed
• Phase II Study of Lucanix™ in Patients With Stages II-IV Non-Small Cell Lung Cancer — Completed
• An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer — Completed
• Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma — Completed
• ARQ 197 in Subjects With Metastatic Solid Tumors — Completed
• Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases — Completed